Triclabendazole and fascioliasis : reports on individual drugs
No Electronic Version
View StatisticsShow Statistical Information
Showing items related by title and MeSH subject.
Evaluation of two doses of triclabendazole in treatment of patients with combined schistosomiasis and fascioliasis Osman, M.M.; Shehab, A.Y.; Zaki, A.; Farag, H.F. (2011)To determine the safety and efficacy of 2 consecutive doses of triclabendazole [TCBZ] in the treatment of Schistosoma mansoni infection in human cases infected with both S. mansoni and Fasdola spv we conducted afield survey involving 6314 individuals from 15 villages. The overall prevalence of schistosomiasis alone was 15.8%, of fascioliasis alone 2.2%, and of combined infection 0.7%. Treatment with 2 doses of TCBZ was given to the 49 cases with combined infection. Eight weeks after treatment, the cure rate was 96% for fascioliasis and was 32.7% ...